Beanblock®
Browse all Indena’s documents about products, events, company information and so much more.
Go to sectionPeer-reviewed science on Beanblock®
A human study on 12 healthy subjects showed that Beanblock® modulates postprandial glucose, insulin and C-peptide excursions, suitably managing ghrelin secretion and satiety sensations. Oral administration of Beanblock® results in favourable increments in plasma glucose (15.4% v. 26.1% at 30 min), insulin (981% v. 1325% between 45 and 120 min) and C-peptide (350% v. 439% between 30 and 90 min) in comparison to a mixed balanced meal without any supplementation.
Figures 1, 2, 3: Glucose, insulin and C-peptide changes (%), at 30, 60, 90, 120, 180 minutes, associated with Beanblock® supplementation (black) or not (white).2
BIBLIOGRAPHY
1Arai et al., Diabetes Metab. Syn. Obes. Targ. Ther. 2:145-153 (2009).
2Spadafranca, A., et al., Br. J. Nutr. 109(10): p. 1789-95 (2013).
Sorry, our website doesn't support IE11 and older versions
For a better experience try a modern browser:
This is a private file, to request the download of this resource, please fullfill the fields below.